Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

For the latest in biomarkers & precision medicine, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Watch Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Biomarker Discovery & Development

Breath Biopsy Omni For Comprehensive & Reliable Detection Of VOC Biomarkers In Breath

On-Demand Webinar featuring Dr Elizabeth Crone, Business Development Manager at Owlstone & Dr Hsuan (Tina) Chou, Biomarker Scientist at Owlstone
Read More
Clinical Development

Toxicity Markers of Cognitive Deterioration in Young Cancer Sufferers

Cancer-related cognitive impairment in young adults found pre-treatment, study reports.
Read More
Biomarker Discovery & Development

Are Neuroimmune Proteins the Key to Neurodegenerative Disease Diagnosis?

Unique neuroinflammatory signatures and pathways present in tauopathies could provide greater insight into distinct mechanisms of disease.
Read More
Clinical Development

Implementing Patient-Centricity into Biomarker Clinical Trials

How can we better define patient-centric clinical trials within the drug development process?
Read More
Clinical Development

Cervical Indicators of HIV Risk Found

Study finds predictive link between genital herpes and HIV.
Read More
Diagnostic Development

Predicting Preeclampsia Risk with Placental Proteins

A new study by Cedars-Sinai could identify protein biomarkers for preeclampsia.
Read More
Clinical Development

Novel Microbial Immunotherapies for Bladder Cancer Treatment

The potential oncolytic applications of Salmonella ZH9 include its use in mitigating diseases such as bladder cancer, with a demonstrated therapeutic effect in cancer models.
Read More
Clinical Development

Patient Engagement in Biomarker Development

Christopher Conn, Director of Diagnostics Strategy at Amgen, leads a Discussion Group on patient testing and engagement in biomarker clinical trials.
Read More
Biomarker Discovery & Development

Biomarker Testing Consolidation and Implementation Using Multiplex Immunofluorescence

Multiplex immunofluorescence is gaining prevalence in oncology diagnostics; what makes it so effective, and how is it being brought into the clinic?
Read More
Clinical Development

Biomarkers for NASH Symposium: Most Anticipated Presentation

Discover key event highlights from Oxford Global's upcoming Biomarkers for NASH Symposium 2022.
Read More
Clinical Development

Scientists at Stanford Medicine Predict Who Will Develop Vaccine Immunity

A gene signature found in antibody-producing cells could accelerate vaccine development.
Read More
Biomarker Discovery & Development

New Therapeutic Target for Aggressive Breast Cancer

Scientists at VCU Massey Cancer Center pinpoint druggable target in aggressive breast cancer.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers